| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 0 | $15.00 | 19 Jan 2023 | Direct | |
| AVEO PHARMACEUTICALS, INC. | Chief Commercial Officer | Stock Option (Right to Buy) | 0 | 19 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323002191-ferraresso-michael-2023-01-19 | AVEO PHARMACEUTICALS, INC. | 19 Jan 2023 | 7 | -$245,175 | 4 | Chief Commercial Officer | 19 Jan 2023, 16:15 |
| /report/000162828022003057-ferraresso-michael-2022-02-15 | AVEO PHARMACEUTICALS, INC. | 15 Feb 2022 | 1 | $0 | 4 | Chief Commercial Officer | 17 Feb 2022, 16:01 |
| /report/000089924321032613-ferraresso-michael-2021-08-10 | AVEO PHARMACEUTICALS, INC. | 10 Aug 2021 | 1 | +$14,996 | 4 | Chief Commercial Officer | 11 Aug 2021, 19:49 |
| /report/000162828022014324-ferraresso-michael-2021-03-10-restatement | AVEO PHARMACEUTICALS, INC. | 10 Mar 2021 | 0 | $0 | 3/A | Chief Commercial Officer | 13 May 2022, 15:51 |